Quantification of hemostatic proteins and activation products in synovial fluids from arthritic joints prior to and after induction of chemical synoviorthesis

Pathophysiology of Haemostasis and Thrombosis

Volumn 26, Issue 3, 1996, Pages 170-177

  Römisch, Jürgen ^a   Krahl, Ute ^a   Hock, Johann ^a   Bläser, Jörg ^b   Fricke, Reinhard ^c   Maasjosthusmann, Ulrich ^c   Tschesche, Harald ^b  

^a Research Laboratories   (Germany)

^b BIELEFELD UNIVERSITY   (Germany)

^c Klinik für Rheumatologie Handchirurgie Rheumazentrum Oberammergau   (Germany)

Author keywords

Activation markers; Chemical synoviorthesis; Hemostatic proteins; Rheumatoid arthritis; Synovial fluid

Indexed keywords

ALPHA 2 ANTIPLASMIN; ALPHA 2 MACROGLOBULIN; ANTITHROMBIN III; BLOOD CLOTTING FACTOR 13; C REACTIVE PROTEIN; COMPLEMENT; ELASTASE; FIBRINOGEN; KININOGEN; PLASMIN; PROTHROMBIN FRAGMENT 1.2; UNCLASSIFIED DRUG;

ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID LEVEL; SYNOVIORTHESIS;

ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; BLOOD COAGULATION FACTORS; BLOOD PROTEINS; COMPLEMENT SYSTEM PROTEINS; FEMALE; FIBRINOLYSIS; HEMOSTASIS; HUMANS; INJECTIONS, INTRA-ARTICULAR; KNEE JOINT; MALE; SYNOVIAL FLUID; SYNOVIAL MEMBRANE;

EID: 0029992187     PISSN: 14248832     EISSN: 14248840     Source Type: Journal    
DOI: 10.1159/000217203     Document Type: Article

References (37)

1. Harris ED Jr: Pathogenesis of rheumatoid arthritis: A disorder associated with dysfunctional immunoreg-ulation; in Gallin JI, Goldstein IM, Snyderman R (cds): Inflammation: Basic Principles and Clinical Correlates. New York, Raven Press, 1988, pp 751-772.
2. Kimball ES, Goss JL: Angiogenesis in pannus formation. Agents Actions 1991;34:329-331.
3. Koch AE, Polverini PJ. Leibovich SJ: Stimulation of neovascularization by human rheumatoid synovial tissue macrophages. Arthritis Rheum 1986;29:471-478.
4. Schuhmacher HR, Kitridou RC: Synovitis of recent onset. Arthritis Rheum 1972;15:465-485.
5. Geiler G: Pathology of primary inflammatory and primary degenerative changes in joints. Z Gesamte Inn Med 1987;42:409-413.
6. Alsalameh S, Kalden JR, Burmester GR: Die Rolle von Zytokinen und Wachstumsfaktoren bei der rheumatoiden Gelenkdestruktion. Z Rheumatol 1991;50:347-359.
7. Harris ED Jr: Rheumatoid arthritis: Pathophysiology and implications for therapy. N Engl J Med 1990:322: 1277-1289.
8. Mochan E, Uhl J: Elevations in synovial fluid plasminogen-activator in patients with rheumatoid arthritis. J Rheumatol 1984; 11:123-128.
9. Kikuchi H, Tanaka S, Matsuo O: Plasminogen activator in synovial fluid from patients with rheumatoid arthritis. J Rheumatol 1987; 14:439-445.
10. Walakovits LA, Moore VL, Bhard-waj N, Gallick GS, Lark MW: Detection of stromelysin and collage-nase in synovial fluid from patients with rheumatoid arthritis and post-traumatic knee injury. Arthritis Rheum 1992;35:35-42.
11. Huet G, Flipo RM, Richet C, Thie-baut C, Demeyer C, Balduyck M, Duqucsnoy B. Degand P: Measurement of elastase and cysteine protéinases in synovial fluid of patients with rheumatoid arthritis, sero-negative spondylarthropaties and osteoarthritis. Clin Chem 1992;38: 1694-1697.
12. Maciewicz RA, Etherington DJ: Enzyme immunoassay for cathcpsins B and L in synovial fluids from patients with arthritis. Biochem Soc Trans 1988;16:812-813.
13. Whaley K: Measurement of complement activation in clinical practice. Complement Inflammation 1989;6: 96-193.
14. Antes U, Heinz HP, Schultz D. Brackertz D. Loos M: Clq-bcaring immune complexes detected by a monoclonal antibody to human Clq in rheumatoid arthritis sera and synovial fluids. Rheumatol Int 1991; 10:245-250.
15. Kawakami M, Kawagoc M, Harigai M, Hara M, Hirose T, Hirosc W, Norioka KI, Suzuki K, Kitani A, Nakamura H: Elevated plasma levels of a2-plasmin inhibitor-plasmin complex in patients with rheumatic diseases. Arthritis Rheum 1989;32: 1427-1433.
16. Schuberts, S. Dreher R, Kraus M: Coagulation and fibrinolysis in plasma and synovial fluid of patients with inflammatory joint disease. Ann Hematol 1993;66:263.
17. Kästner P, Plötncr G, Peter A: Zyto-logischc und biochemische Veränderungen in der Synovialflüssigkeit nach Varicocideinwirkung. Z Inn Med 1973;22:694-697.
18. Amctt FC, Edwrthy SM, Block DA, McShane DJ. Fires JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Mcdsger TA, Mitchel DM, Neustaad DH, Pinalls RS. Schaller JG. Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-324.
19. Larsen A, Dale K, Eck M: Radio-graphic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn 1977;18:481-491.
20. Brewcrton DA: Causes of arthritis. Lancet 1988;i: 1063-1066.
21. Cooke TD, Hurd ER, Jasin HE: Identification of immunoglobulins and complement in rheumatoid articular collagenous tissues. Arthritis Rheum 1975;18:563-576.
22. Morgan BP: Mechanisms of tissue damage by the membrane attack complex of complement. Complement Inflammation 1989;6:104.
23. Sanders ME, Kopicky JA, Wigley FM, Shin ML, Frank MM, Joiner KA: Membrane attack complex of complement in rheumatoid tissue demonstrated by immunoHuorcs-ccnt microscopy. J Rheumatol 1986; 13:1028.
24. Morgan BP, Daniels RH, Williams BD: Measurement of terminal complement complexes in rheumatoid arthritis. Clin Exp Immunol 1988; 83:473.
25. Jose PJ. Moss IK, Maini RN, Williams TJ: Measurement of the che-motactic complement fragment C5a in rheumatoid synovial fluids by radioimmunoassay: Role of C5a in the acute inflammatory phase. Ann Rheum Dis 1990;49:747-752.
26. Kitsis E, Weissmann G: The role of the neutrophil in rheumatoid arthritis. Clin Orthop 1991;65:63-72.
27. Nathan CF: Neutrophil activation on biologic surfaces: Massive secretion of H2O2 in response to products of macrophages and lymphocytes. J Clin Invest 1987;80:1550-1560.
28. Chatham WW, Swain R, Frohsinn H, Heck LW, Miller EJ. Blackburn WD: Degradation of human articular cartilage by neutrophils in synovial fluid. Arthritis Rheum 1993:36: 51-58.
29. Gysen P, Malaise M, Gaspar S, Franchimont P: Measurement of proteoglycans, clastase, collagenase and protein in synovial fluid in inflammatory and degenerative arthropathies. Clin Rheum 1985;4: 39-50.
30. Gough SCL, Pullar T, Rice PJS, Zc-bouni L, Grant L: Fibrinolytic activity in rheumatic arthritis and the effects of prednisolone therapy. Fibrinolysis 1993;7:97-102.
31. Blaser J. Maasjosthusmann U, Trie-bcl S. Rômisch J. Krahl-Matcblow-ski U, Frcudenberg W, Fricke R, Tschesche H: Determination of metalloproteinases, urokinasc-plasmin-ogcn-activator and their inhibitors in the synovial fluids of patients with rheumatoid arthritis during chemical synoviorthesis. Rheumatology, in press.
32. Melmon KL, Cline MJ: Kallikrein activator and kinase in human granulocytes: A model of inflammation; in Rocha E, Silva M (eds): Symposium on Vasoactive Polypeptides: Bradykinin and Related Kinins. Oxford, Pergamon Press, 1967.
33. Weinberg JB, Pippcn ANM, Greenberg SC: Extrvascular fibrin formation and dissolution in synovial tissue of patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 1991;34:996-1005.
34. Carmassi F, Dc Negri F, Morale M, Puccctti R, Song KY, Chung SI: Assessment of coagulation and fibimo-lysis in synovial fluid of rheumatoid arthritis patients. Fibrinolysis 1994; 8:162-171.
35. Knâupcr V, Triebel S, Reinke H, Tschesche H: Inactivatioan of human Cl-inhibitor by human PMN leucocyte matrix metalloproteinases. FEBS Lett 1991;290:99-102.
36. Abbink JJ. Kamp AM, Nuijcns JH. Swaak TJG, Hack E: Proteolytic inactivation of cq-antitrypsin and cq-antichymotrypsin by neutrophils in arthritic joints. Arthritis Rheum 1993;36:168-180.
37. Redy VJ. Pizzo SV, Weiss SJ: Functional inactivation and structural disruption of human α-mncroglo-bulin by neutrophils and eosinophils. J Biol Chem 1989;264:13801-13809.